Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNF alpha levels during treatment. [electronic resource]
Producer: 20030422Description: 375-80 p. digitalISSN:- 0145-2126
- Adult
- Aged
- Disease Progression
- Drug Resistance, Neoplasm
- Endothelial Growth Factors -- blood
- Etanercept
- Female
- Hepatocyte Growth Factor -- blood
- Humans
- Immunoglobulin G -- therapeutic use
- Intercellular Signaling Peptides and Proteins -- blood
- Interleukin-6 -- blood
- Lymphokines -- blood
- Male
- Middle Aged
- Multiple Myeloma -- blood
- Neoplasm Proteins -- analysis
- Pilot Projects
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Salvage Therapy
- Treatment Failure
- Tumor Necrosis Factor-alpha -- analysis
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factors
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.